Jayakrishna Ambati, MD, discusses phase 2 K8 results in GA, its inflammasome mechanism, and dosing designed for convenience.

Hunter Cherwek, MD, of Orbis discusses summit commitments, eye care workforce training, and AI in low-resource settings.

Technician-led screening catches hidden ocular surface disease before cataract surgery and helps decide when to delay surgery ...

Eye care providers urged FDA advisers to approve SYD-101, citing myopia’s lifelong risks, compounding gaps and STAR trial ...

An estimated 9.6 million people in the US have diabetic retinopathy, and roughly 1 in 3 patients with diabetes miss annual ...

Duravyu missed wet AMD noninferiority twice, DAYBREAK met its end points, and optogenetics won the Nobel as son-vec posted ...

In more than 90,000 people across TWO independent cohorts, those with atrial fibrillaion (AF) had a thinner macular ganglion ...

AREDS-based review links Mediterranean diet adherence to slower AMD and GA progression, as a complement to AREDS2 supplements ...

Carreño discusses oral protein-folding correction for RHO-adRP, early-phase trial end points and genetic eligibility.

The patient was highly symptomatic despite the stable vision. Goldberg said a key takeaway for attendees was that “visual ...

Murtaza K. Adam, MD, reviews 3 patient cases to explore referral patterns, neovascularization after treatment, and barriers to care.

Luma, an eye-tracking and assessment tool, helps eye care professionals gain objective insights into visual performance.